日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Pulmonary vasodilator therapy is associated with improved survival in COPD-PH with pulmonary vascular predominance

肺血管扩张剂治疗与以肺血管病变为主的慢性阻塞性肺疾病合并肺动脉高压患者的生存率提高相关。

期刊:BMC Pulmonary Medicine
影响因子:2.8
doi:10.1186/s12890-026-04203-4
Caton, Taylor; Pescatore, Jay; Naranjo, Mario; Gayen, Shameek
肺动脉高压
心血管
慢性阻塞性肺疾病
发表日期：2026
文献求助 收藏

Antifibrotic therapy combined with pulmonary vasodilator therapy may improve survival in patients with pulmonary fibrosis and pulmonary hypertension: a retrospective cohort study

抗纤维化治疗联合肺血管扩张剂治疗可能改善肺纤维化合并肺动脉高压患者的生存率：一项回顾性队列研究

期刊:Therapeutic Advances in Respiratory Disease
影响因子:3
doi:10.1177/17534666251326743
Cardillo, Christian; Criner, Gerard J; Gayen, Shameek
肺动脉高压
心血管
发表日期：2025
文献求助 收藏

The FEV1/DLCO Ratio as an Effective Predictor of Severity and Survival in COPD-Associated Pulmonary Hypertension: A Retrospective Analysis

FEV1/DLCO 比值作为 COPD 相关肺动脉高压严重程度和生存率的有效预测指标：一项回顾性分析

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14051606
Patel, Ria; Pescatore, Jay; Gayen, Shameek
肺动脉高压
COPD
心血管
慢性阻塞性肺疾病
发表日期：2025
文献求助 收藏

Development of the pulmonary fibrosis, pulmonary vascular resistance, six minute walk distance, B-type natriuretic peptide, age (PVD-B65) risk score for patients with chronic lung disease and pulmonary hypertension

慢性肺病合并肺动脉高压患者的肺纤维化发展、肺血管阻力、六分钟步行距离、B型钠尿肽、年龄（PVD-B65）风险评分

期刊:BMC Pulmonary Medicine
影响因子:2.8
doi:10.1186/s12890-025-03538-8
Gayen, Shameek; Pescatore, Jay; Bittner, Matthew; Naranjo, Mario; Criner, Gerard J; Weaver, Sheila
肺动脉高压
心血管
发表日期：2025
文献求助 收藏

Revised Precapillary Pulmonary Hypertension Criteria and Their Prognostic Value in IPF Transplant Waitlist Survival

修订后的毛细血管前肺动脉高压标准及其在特发性肺纤维化移植等待名单生存率中的预后价值

期刊:Pulmonary Circulation
影响因子:2.5
doi:10.1002/pul2.70046
Dhanani, Zehra; Nicholson, Michael J; Gayen, Shameek
肺动脉高压
心血管
特发性肺纤维化
发表日期：2025
文献求助 收藏

Clinical review of non-invasive ventilation

无创通气的临床综述

期刊:European Respiratory Journal
影响因子:21
doi:10.1183/13993003.00396-2024
Criner, Gerard J; Gayen, Shameek; Zantah, Massa; Dominguez Castillo, Eduardo; Naranjo, Mario; Lashari, Bilal; Pourshahid, Seyedmohammad; Gangemi, Andrew
发表日期：2024
文献求助 收藏

Elevated pulmonary vascular resistance is associated with increased lung transplant waitlist mortality among patients with chronic obstructive pulmonary disease and pulmonary hypertension: a retrospective cohort analysis

肺血管阻力升高与慢性阻塞性肺疾病合并肺动脉高压患者的肺移植等待名单死亡率增加相关：一项回顾性队列分析

期刊:Respiratory Research
影响因子:5
doi:10.1186/s12931-024-02674-9
Gayen, Shameek K; Zulty, Mary; Criner, Gerard J
肺动脉高压
心血管
慢性阻塞性肺疾病
发表日期：2024
文献求助 收藏

Predictors of Residual Pulmonary Vascular Obstruction after Acute Pulmonary Embolism Based on Patient Variables and Treatment Modality

基于患者变量和治疗方式的急性肺栓塞后残余肺血管阻塞的预测因素

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm13144248
Ho, Truong-An Andrew; Pescatore, Jay; Lio, Ka U; Rali, Parth; Criner, Gerard; Gayen, Shameek
发表日期：2024
文献求助 收藏

The Evolution of Central Venous-to-arterial Carbon Dioxide Difference (PCO(2) Gap) during Resuscitation Affects ICU Outcomes: A Prospective Observational Study

复苏过程中中心静脉-动脉二氧化碳分压差（PCO₂差值）的变化影响ICU预后：一项前瞻性观察研究

期刊:Indian Journal of Critical Care Medicine
影响因子:1.5
doi:10.5005/jp-journals-10071-24680
Zirpe, Kapil G; Tiwari, Anand M; Kulkarni, Atul P; Vaidya, Hrishikesh S; Gurav, Sushma K; Deshmukh, Abhijit M; Suryawanshi, Prasad B; Kapse, Upendrakumar S; Bhoyar, Abhaya P; Dhawad, Piyush A; Mukherjee, Shameek
发表日期：2024
文献求助 收藏

Pulmonary hypertension and lung transplantation waitlist outcomes for hypersensitivity pneumonitis

过敏性肺炎患者的肺动脉高压和肺移植等待名单结局

期刊:
影响因子:
doi:10.1016/j.jhlto.2024.100157
Nicholson, Michael J; Dhanani, Zehra; Gayen, Shameek
肺炎
肺动脉高压
心血管
发表日期：2024
文献求助 收藏